This is a great question, and this is really something that we’re excited about. Again, our vision is for us to have this platform that anyone could access. And when on this platform, you can basically select any cancer type, any regimen, and see how well these patients are doing in the real world. Then you can imagine having a new regimen and trying to compare the efficacy of that regimen to what we’re seeing for the standard of care in the real world...
This is a great question, and this is really something that we’re excited about. Again, our vision is for us to have this platform that anyone could access. And when on this platform, you can basically select any cancer type, any regimen, and see how well these patients are doing in the real world. Then you can imagine having a new regimen and trying to compare the efficacy of that regimen to what we’re seeing for the standard of care in the real world. This would compare to a modern clinical trial control arm that we can use and that could potentially help us alleviate some of the resources that are needed for clinical trials.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
